Advancements in the Treatment of Multiple Sclerosis - 2022 Update

Over the past two decades, the field of multiple sclerosis (MS) has achieved significant milestones, particularly in advancing the understanding of disease pathogenesis and available treatments for patients living with MS. Refinements of diagnostic criteria and a revolutionary expansion of therapeutics, targeting both relapsing and progressive forms of MS, have made notable impacts on patient outcomes and quality of life. In contrast to the early 1990s, when only steroids could manage acute exacerbations, there are now over 20 FDA approved disease modifying therapies in this brimming armamentarium. Despite such advancements, there is still much work to be done to improve MS care.